Hemophilia of Georgia’s Trot to Clot Walk Raises Nearly $24,000 to Benefit Georgians with Inherited Bleeding Disorders
June 29, 2010
Hemophilia of Georgia’s first Trot to Clot Walk raised nearly $24,000 to fund programs and services for people in Georgia who have bleeding disorders. The Trot to Clot walk was held June 12, 2010 at East Cobb Park in Marietta. Approximately 125 people participated in the Walk and many more made contributions to support individual walkers.
According to Hemophilia of Georgia CEO Trish Dominic, “we are so thankful to our corporate sponsors, the walk participants, the volunteers, and of course, the walkers, for a very successful first fundraising walk. The money we raised will ensure that we can continue to offer valuable educational and networking programs for people who have hemophilia, von Willebrand Disease, and other inherited bleeding disorders.”
The following companies served as corporate sponsors of the Trot to Clot Walk: Premier Sponsors Hewlett-Packard, Novo Nordisk, and Talecris Biotherapeutics; Partner Sponsors Baxter Healthcare, CSL Behring, LLC, Green Oaks Dental and Williams Benator & Libby, LLP; and Patron Sponsors Accredo Health Group and Cruser & Mitchell, LLP. Local sponsors included Chick fil A, LA Fitness, Sport Clips, and Dunkin’ Donuts. After completing the two-mile walk, participants visited sponsor booths and enjoyed the playground.
About Hemophilia of Georgia
Hemophilia of Georgia is a nonprofit organization dedicated to providing services and support for Georgians who have hemophilia, von Willebrand Disease, and other inherited bleeding disorders. The only agency of its kind in the state, Hemophilia of Georgia works to enhance clients’ care and quality of life while actively pursuing a cure through research funding. HoG’s nonprofit pharmacy provides convenient home delivery of clotting factor and other medications at competitive prices. Hemophilia of Georgia exists so that people in Georgia affected by bleeding disorders live as normally and productively as possible. Additional information is available online at www.hog.org.
About Hemophilia
Hemophilia is a hereditary genetic disorder in which a person’s blood is not able to clot normally. In normal blood, proteins called clotting factors work together to form a clot whenever bleeding occurs. The person with hemophilia lacks or doesn’t have enough of a certain clotting factor so the blood can’t make a clot. Hemophilia is a very rare disorder, affecting about 17,000 people in the United States. People with hemophilia stop bleeding by taking an injection of the clotting factor that is missing from their blood. However, the clotting factor used to treat hemophilia is very expensive. Some patients reach their lifetime insurance maximum at very young ages